Indication:
U.S. FDA APPROVED DRUGS DURING 2024
Sr.No- 1
Name of the Drug- ZELSUVMI
Active Ingredient - Berdazimen
Pharmacological Classification-
To treat muscular contra closing
Date of Approval- 1 /1/2024
(Ref- FDA approved List 2020)
HIGHLIGHTS OF PRESCRIBING INFORMATION